Scott Cormack
2012
In 2012, Scott Cormack earned a total compensation of $1.6M as President and Chief Executive Officer at OncoGenex Pharmaceuticals, a 140% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $257,577 |
|---|---|
| Option Awards | $374,148 |
| Salary | $520,358 |
| Stock Awards | $487,500 |
| Total | $1,639,584 |
Cormack received $520.4K in salary, accounting for 32% of the total pay in 2012.
Cormack also received $257.6K in non-equity incentive plan, $374.1K in option awards and $487.5K in stock awards.
Rankings
In 2012, Scott Cormack's compensation ranked 4,230th out of 11,487 executives tracked by ExecPay. In other words, Cormack earned more than 63.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,230 out of 11,487 | 63rd |
Division Manufacturing | 1,473 out of 4,253 | 65th |
Major group Chemicals And Allied Products | 335 out of 1,198 | 72nd |
Industry group Drugs | 205 out of 920 | 78th |
Industry In Vitro and In Vivo Diagnostic Substances | 10 out of 47 | 79th |
Source: SEC filing on April 24, 2014.
Cormack's colleagues
We found three more compensation records of executives who worked with Scott Cormack at OncoGenex Pharmaceuticals in 2012.